Cardiovascular risk age: concepts and practicalities

Marie Therese Cooney1, Erkki Vartiainen, Tiina Laatikainen

  • 1Department of Cardiology, Adelaide Meath Hospital, Dublin, Ireland.

Insights

Risk age is a novel way to communicate cardiovascular disease (CVD) risk, especially for younger individuals. This method helps patients understand their risk level, potentially encouraging healthier lifestyle choices.

Area of Science:

  • Cardiovascular disease risk assessment
  • Preventive cardiology
  • Health communication

Background:

  • Cardiovascular disease (CVD) risk increases with age and risk factors.
  • A younger individual with multiple risk factors can have a similar risk profile to an older individual with fewer risk factors.
  • The concept of 'risk age' aims to provide a more intuitive understanding of an individual's CVD risk.

Purpose of the Study:

  • To derive a generic equation for calculating risk age.
  • To construct risk age charts for practical application.
  • To investigate if risk age remains consistent across different cardiovascular disease (CVD) endpoints.

Main Methods:

  • A generic 10-year CVD risk formula was equated to a formula with ideal risk factors to solve for 'risk age' (x).
  • Risk ages were calculated for participants in the FINRISK study using both fatal CVD events and total CVD events (fatal and non-fatal).
  • The correlation between risk ages derived from different endpoints was analyzed.

Main Results:

  • A generic equation for risk age was successfully derived.
  • A specific table for Systematic COronary Risk Evaluation (SCORE) risk ages was created due to age being a baseline factor in that system.
  • Risk age demonstrated consistency across different CVD endpoints (fatal vs. total events).
  • The derived risk age equation is independent of baseline survival, negating the need for recalibration.

Conclusions:

  • Risk age offers an intuitive communication tool for CVD risk, particularly beneficial for younger patients.
  • Utilizing risk age may encourage younger individuals to adopt healthier lifestyles.
  • Clinical decisions regarding CVD prevention should still primarily rely on absolute risk assessment as per current guidelines.
Abstract

Related Concept Videos

Assessment of the Cardiovascular System I: Subjective Data01:23

Assessment of the Cardiovascular System I: Subjective Data

A thorough health history and physical assessment are essential for identifying cardiovascular disease (CVD) symptoms and distinguishing them from other health issues.
Initial Enquiry
Ask the patient about their primary concern and thoroughly explore all reported symptoms.
Medical History
Investigate past illnesses affecting the cardiovascular system, such as angina, anemia, rheumatic fever, congenital heart disease, stroke, thrombophlebitis, dysrhythmias, varicosities
Inquire about symptoms...
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Pharmacodynamics in Geriatric Patients: Effects of Age01:27

Pharmacodynamics in Geriatric Patients: Effects of Age

Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
Cardiovascular Drugs: Classification based on Therapeutic Indications01:18

Cardiovascular Drugs: Classification based on Therapeutic Indications

Cardiovascular diseases, encompassing a range of conditions, can significantly affect the heart's operations and the overall circulatory system. These conditions impair the heart's ability to pump blood, leading to a deficit in oxygen supply to crucial organs. Anomalies in the heart's electrical system, known as arrhythmias, can cause heartbeats to accelerate or slow down. Usually, heart rates increase during physical activity and decrease while resting or sleeping. However, frequent irregular...